Search Within

Ritesh Rajesh Kotecha

Formats
  1. Meeting Abstract (47)
  2. Journal Article (39)
  3. Review (4)
  4. Editorial (2)
  5. Correspondence (1)
  6. Research Letter (1)
Groups
  1. Department of Medicine (94)
  2. Genitourinary Oncology Service (94)
  3. Hematologic Malignancies, Division of (94)
  4. Solid Tumor Oncology Division (94)
  5. Weinberg Fellows (94)
  6. Population Sciences Research Program (45)

More Groups

People
  1. Martin Voss (65)
  2. Robert Motzer (62)
  3. Maria Carlo (43)
  4. Chung-Han Lee (42)
  5. Abraham Hakimi (37)
  6. Darren Feldman (30)

More People

Years
  1. 2025 (15)
  2. 2024 (17)
  3. 2023 (14)
  4. 2022 (17)
  5. 2021 (16)
  6. 2020 (7)

More Years

Publications
  1. Journal of Clinical Oncology (35)
  2. European Urology (5)
  3. Clinical Cancer Research (4)
  4. Cancer (3)
  5. European Urology Oncology (3)
  6. Journal of Pain and Symptom Management (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (37)
  2. Elsevier Inc. (11)
  3. Elsevier Science, Inc. (8)
  4. American Association for Cancer Research (7)
  5. Biomed Central Ltd (5)
  6. Wiley Blackwell (4)

More Publishers

Results (94)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • KEAP1 mutated renal cell carcinoma (RCC): Characterization of an emerging molecularly defined RCC subtype
    Meeting Abstract

    Carlo, M.; Chen, Y. B.; Knezevic, A.; Zong, G.; Bakouny, Z.; Kemel, Y.; Latham, A.; Liu, Y. L.; Shah, N. J.; Feldman, D. R.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Clear and non-clear cell renal cell carcinomas and the ability to engage in oxidative phosphorylation
    Meeting Abstract

    Bakouny, Z.; Boscenco, S.; Cui, R.; Ryu, K.; Kotecha, R. R.; Carlo, M.; Voss, M. H.; Hakimi, A. A.; Motzer, R. J.; Gammage, P. A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Real-world clinical outcomes of sacituzumab govitecan after prior exposure to enfortumab vedotin in patients with metastatic urothelial carcinoma
    Journal Article

    Sternschuss, M.; Toumbacaris, N.; Das, J. P.; Powles, T.; Kotecha, R. R.; Laccetti, A. L.; Xiao, H.; Feld, E.; McHugh, D. J.; Keegan, N. M.; more...
    ESMO Open (2025)

    Fulltext@MSK | Save
  • A phase I dose-escalation study of the HIF-2 alpha inhibitor DFF332 in patients with advanced clear-cell renal cell carcinoma
    Journal Article

    Pal, S. K.; Bernard-Tessier, A.; Grell, P.; Gao, X.; Kotecha, R. R.; Picus, J.; de Braud, F.; Takahashi, S.; Wong, A.; Suárez, C.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Outcomes with first-line ipilimumab and nivolumab for patients with metastatic renal cell carcinoma by number of doses
    Meeting Abstract

    Doshi, S. D.; Sanmiguel, A. L.; Knezevic, A.; Kotecha, R. R.; Shah, N. J.; Carlo, M.; Feldman, D. R.; Motzer, R. J.; Voss, M. H.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Association between clonal hematopoiesis and survival after nephrectomy in patients with renal cell carcinoma
    Meeting Abstract

    Khandwala, Y.; Ruthen, N.; Kotecha, R. R.; Russo, P.; Coleman, J.; Reznik, E.; Hakimi, A. A.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Multi-institutional analysis of immune-oncology combination therapy for metastatic MiT family translocation renal cell carcinoma
    Journal Article

    Ged, Y.; Touma, A.; Contreras, L. M.; Elias, R.; Van Galen, J.; Cupo, O.; Baraban, E.; Singla, N.; Lee, C. H.; Pal, S.; more...
    Journal of Immunotherapy (2025)

    Fulltext@MSK | Save
  • Clinical outcomes and targeted genomic analysis of renal cell carcinoma brain metastases treated with stereotactic radiosurgery
    Journal Article

    Ma, J.; del Balzo, L.; Walch, H.; Khaleel, S.; Knezevic, A.; Flynn, J.; Zhang, Z.; Eichholz, J.; Doshi, S. D.; Voss, M. H.; more...
    European Urology Oncology (2025)

    Fulltext@MSK | Save
  • Gene expression of prostate-specific membrane antigen (FOLH1) in clear cell renal cell carcinoma predicts angiogenesis and response to tyrosine kinase inhibitors
    Journal Article

    Khaleel, S.; Perera, M.; Papa, N.; Kuo, F.; Golkaram, M.; Rappold, P.; Kotecha, R. R.; Coleman, J.; Russo, P.; Motzer, R.; more...
    Urologic Oncology: Seminars and Original Investigations (2025)

    Fulltext@MSK | Save
  • Real-time monitoring in renal cell carcinoma with circulating tumor DNA: A step forward, but how far?
    Editorial

    Zengin, Z. B.; Kotecha, R. R.
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save